Enrolling by invitationPhase 2NCT03338387
Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia
Studying NON RARE IN EUROPE: Anorexia nervosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charles University, Czech Republic
- Principal Investigator
- Kvido Smitka, M.D., Ph.D.Charles University, Czech Republic
- Intervention
- Acipimox(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 18-30 years · FEMALE
- Timeline
- 2003 – 2026
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03338387 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Anorexia nervosa
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07060534Building Healthy Eating and Self-Esteem Together for University StudentsUniversity of Kansas
- RECRUITINGNCT07339826Overview of Knowledge and Practices Among Healthcare Professionals Treating Eating DisordersUniversity Hospital, Strasbourg, France
- RECRUITINGNANCT07082777Recovery in Telling Life StoriesUniversity of Aarhus
- RECRUITINGNANCT07017322Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating DisordersRogers Behavioral Health
- RECRUITINGNANCT07468188Diabetes Body Project 2Joslin Diabetes Center
- ENROLLING BY INVITATIONNANCT06863909Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral TherapyUniversity Hospital Tuebingen
- RECRUITINGNANCT06551974INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating DisordersUniversity of Palermo
- RECRUITINGNCT06532734Barrett's Esophagitis in Anorexia Nervosa Binge/Purge SubtypeDenver Health and Hospital Authority